The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes-Reference-Cited by-同舟云学术

The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes

Published:2014-12 Issue:12 Volume:121 Page:2443-2451
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Chew Emily Y.^ORCID,Davis Matthew D.,Danis Ronald P.,Lovato James F.,Perdue Letitia H.,Greven Craig,Genuth Saul,Goff David C.,Leiter Lawrence A.^ORCID,Ismail-Beigi Faramarz,Ambrosius Walter T.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference23 articles.

1. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: design and methods;Am J Cardiol,2007

2. Effects of intensive glucose lowering in type 2 diabetes;N Engl J Med,2008

3. Effects of combination lipid therapy in type 2 diabetes mellitus;N Engl J Med,2010

4. Effect of intensive blood pressure control in type 2 diabetes mellitus;N Engl J Med,2010

5. Long term effects of intensive glucose lowering on cardiovascular outcomes;N Engl J Med,2011

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of diabetic retinopathy screening between hospital-based multidisciplinary and general practice-based settings: insights from a regional study in Italy;Acta Diabetologica;2024-08-19

2. Identification of Potential Inhibitors from Medicinal Plant-based Phytochemicals for the Influential C4 Target of Diabetic Retinopathy by Molecular Docking Studies;Current Pharmaceutical Design;2024-08-08

3. Short-Term Clinical Outcomes of Patients with Diabetic Macular Edema Following a Therapy Switch to Faricimab;Journal of Clinical Medicine;2024-08-01

4. Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators;ACS Medicinal Chemistry Letters;2024-07-22

5. Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study;Diabetes, Obesity and Metabolism;2024-07-19